2Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 1982,51:189-199.
3Harris N, Jaffe E, Diebold J, et al. WHO classification of neoplastic diseases of the hematopoietic and lymphoid tisues: report of the clinical advisory committee meeting. J cin Oncol, 1999,17:3835-3849.
4Brunning R, Bennett J, Flandrin G, et al, eds. WHO classification of tumours. Pathology and genetics fo haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001. 61-73.
5Vardiman JW, Harris NL, Brunning RD. The World Health Organization(WHO) classification of the myeloid neoplasms. Blood, 2002,100:2292-2302.
6Mandel K, Dror Y, Poon a, et al. A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC system. J Pediatr Hematol Oncol, 2002,24:596-605.
7Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach tothe WHO classification of myelodysplatic and myeloproliferative disease. Leukemia, 2003, 17:277-282.
8Goasguen JE, Bennett JM. Classification and morphologic teatures of myelodysplastic syndromes. Semin Oncol, 1992,9:4-13.
9Freedman MH, Cohen A, Grunberger T, et al. Central role of tumor necrosis factor, GM-CSF and interlerkin-l in the pathogenesis of juvenile chronic myelogenous leukemia. Br J Haematol, 1992, 80:40-48.
10Mandel K, Dror Y, Poon A, et al. A practical, comprehensive classificatin for pediatric myelodysplastic syndromes: the CCC system. J Pediatr Hematol Oncol, 2003,25(4):426-427.
